Actively Recruiting
Faecal Analyses in Spondyloarthritis Therapy
Led by Region Skane · Updated on 2024-03-06
50
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates the intestinal microbiome and disease activity in patients with spondyloarthropathies receiving immunosuppressive therapy. Patients will be analysed at two time points in reference to two predefined primary endpoints: * Changes in intestinal microbiome * Response to therapy The investigators want to evaluate if successful treatment of spondylarthropathy coincide with specific changes in the gut flora.
CONDITIONS
Official Title
Faecal Analyses in Spondyloarthritis Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfilling the Assessment of SpondyloArthritis International Society classification criteria for spondyloarthropathy
- About to commence treatment with TNF-inhibition
You will not qualify if you...
- Failure to understand protocol
- A history of alcohol abuse
- Any history of diverticulitis
- A history of failure to comply with prescribed medication
- Ongoing biological therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reumatologi SUS Lund, Region Skåne
Lund, Sweden, 221 85
Actively Recruiting
Research Team
K
Kristofer Andréasson, MD PhD
CONTACT
J
Johan Karlsson Wallman, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here